Healius Ltd HLS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- A$0.42
- Day Range
- A$0.41–0.45
- 52-Week Range
- A$0.30–1.07
- Bid/Ask
- A$0.43 / A$0.44
- Shares Outstanding
- 726.18M
- Market Cap
- A$315.89M
- Volume/Avg
- 4M / 5M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.22
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Healius is one of Australia's pathology providers, operating a national network of laboratories and collection centres. Pathology generates nearly all group revenue, the majority of which comes from bulk-billed tests funded through the government's Medicare Benefits Schedule, with the remainder from public hospital contracts, private health funds, and specialty services, including genomics and veterinary pathology.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- 11,000
- Website
- https://www.healius.com.au
Valuation
|
Metric
|
HLS
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.76 |
Price/Sales | 0.22 |
Price/Cash Flow | 1.43 |
Price/Earnings
HLS
Financial Strength
|
Metric
|
HLS
|
|---|---|
Quick Ratio | 0.54 |
Current Ratio | 0.66 |
Interest Coverage | −6.70 |
Quick Ratio
HLS
Profitability
|
Metric
|
HLS
|
|---|---|
Return on Assets (Normalized) | −0.80% |
Return on Equity (Normalized) | −3.01% |
Return on Invested Capital (Normalized) | 1.52% |
Return on Assets
HLS
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|ph<%gt? | LOCK|xFQ | $250B | |||
| Danaher Corp
DHR
| LOCK|wTwR$?Z? | LOCK|rG | $162B | |||
| Agilent Technologies Inc
A
| LOCK|Gq!#>?@f | LOCK|tnj | $49B | |||
| IQVIA Holdings Inc
IQV
| LOCK|W$!r!d | LOCK|YHPvc | $46B | |||
| Waters Corp
WAT
| LOCK|?l@L?> | LOCK|nk | $45B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|d<S?MXg | LOCK|$kX | $45B | |||
| Illumina Inc
ILMN
| LOCK|B#v!b^ | LOCK|^!n< | $41B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|p#n>v>%& | LOCK|^&TMR | $34B | |||
| Quest Diagnostics Inc
DGX
| LOCK|<>PB$X | LOCK|VG?f | $27B | |||
| Labcorp Holdings Inc
LH
| LOCK|Psg&M@#G | LOCK|xtbn | $27B |
United States